P2.01-46 the Efficacy and Safety of 2Nd-Line Nivolumab for Non-Small Cell Lung Cancer in Real-World Practice with Emphasis on Hyperprogession

Journal of Thoracic Oncology(2019)

引用 2|浏览18
暂无评分
关键词
Non-Small Cell Lung Cancer,nivolumab,hyperprogression
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要